Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Pfizer Inc. PFE

Set alert

Price alert · PFE

All alert types
30.84 USD +0.17 +0.55%

As of Nov 3, 10:02 AM ET

Bid
30.83 × 1
Ask
30.84 × 2
30.38 Day range 31.05
23.67 52-week range 30.88
YTD
+23.86%
1 year
+25.06%
Open
30.68
Prev close
30.67
Mkt cap
176.01B
Vol
10.23M
Avg vol
33.91M
EPS
0.76
P/E
40.63
Div yield
5.74%
More statistics
Low
30.38
High
31.05
Forward P/E
10.64
Beta
0.30
Short ratio
4.20
Inst. own
69.11%
Dividend
1.72
Ex-div date
Nov 5, 2026
Earnings
Nov 3, 2026
50-d avg
28.55
200-d avg
26.80
1y target
29.26

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 4, 2026Earnings: 0.77; estimate 0.682; surprise 12.9%
  • Aug 7, 2026Rating: Guggenheim · Buy → Buy
  • Sep 10, 2026Rating: HSBC · Hold → Hold
  • Oct 6, 2026Rating: Scotiabank · Sector Outperform → Sector Outperform
  • Oct 8, 2026Rating: Cantor Fitzgerald · Neutral → Neutral
  • Oct 9, 2026Rating: JP Morgan · Neutral → Neutral
  • Nov 3, 2026Earnings: —; estimate 0.735; surprise —%
Signals (16)
NameDateAgo
RSI: OverboughtOct 22, 20261 week ago
RSI: OverboughtOct 20, 20262 weeks ago
MACD: Buy SignalOct 14, 20262 weeks ago
SMA: BullishOct 9, 20263 weeks ago
SMA: BearishOct 1, 20261 month ago
MACD: Sell SignalOct 1, 20261 month ago
MACD: Buy SignalSep 28, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BearishSep 16, 20261 month ago
MACD: Sell SignalSep 8, 20261 month ago
RSI: OverboughtSep 2, 20262 months ago
RSI: OverboughtAug 25, 20262 months ago
RSI: OverboughtAug 21, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
RSI: OverboughtAug 7, 20262 months ago
SMA: BullishAug 4, 20263 months ago

Analyst view

Consensus: buy

Buy
Price target (mean) 29.26 -5.1% downside
Target (low)
25.00
Target (mean)
29.26
Target (high)
36.00
Ratings (0m) 28 9 buy · 17 hold · 2 sell
  • Strong buy1
  • Buy8
  • Hold17
  • Sell1
  • Strong sell1

Recommendation trend

  • This month 28
  • 1 month ago 28
  • 2 months ago 28

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PFE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.728030.56 – 0.830.87-16.3%15.88B-4.7%19
Next quarter0.706130.63 – 0.830.66+7.0%16.89B-3.8%17
Current year2.962.88 – 3.073.22-8.1%62.23B-0.5%24
Next year2.892.52 – 3.152.96-2.4%59.89B-3.8%22

Upgrades and downgrades

The latest rating changes

PFE analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026JP MorganMaintainedNeutralNeutral
Oct 8, 2026Cantor FitzgeraldMaintainedNeutralNeutral
Oct 6, 2026ScotiabankMaintainedSector OutperformSector Outperform
Sep 10, 2026HSBCMaintainedHoldHold
Aug 7, 2026GuggenheimMaintainedBuyBuy
Jul 13, 2026BMO CapitalMaintainedOutperformOutperform
Jul 13, 2026GuggenheimMaintainedBuyBuy
Jul 10, 2026B of A SecuritiesMaintainedNeutralNeutral
Jul 8, 2026JP MorganMaintainedNeutralNeutral
Jul 6, 2026Cantor FitzgeraldReiteratedNeutralNeutral
Jul 6, 2026HSBCDowngradeBuyHold
Jun 10, 2026RBC CapitalUpgradeUnderperformSector Perform
Apr 29, 2026CitigroupMaintainedNeutralNeutral
Apr 20, 2026RBC CapitalReiteratedUnderperformUnderperform
Apr 16, 2026CICCInitiated—Outperform
Apr 13, 2026UBSMaintainedNeutralNeutral
Apr 10, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Apr 9, 2026B of A SecuritiesMaintainedNeutralNeutral
Mar 24, 2026GuggenheimMaintainedBuyBuy
Mar 17, 2026HSBCMaintainedBuyBuy
Mar 2, 2026Argus ResearchUpgradeHoldBuy
Feb 25, 2026RBC CapitalInitiated—Underperform
Feb 20, 2026BarclaysInitiated—Underweight
Feb 9, 2026Freedom BrokerMaintainedBuyBuy
Feb 4, 2026Cantor FitzgeraldReiteratedNeutralNeutral
Jan 27, 2026Cantor FitzgeraldMaintainedNeutralNeutral
Dec 17, 2025Morgan StanleyMaintainedEqual-WeightEqual-Weight
Dec 15, 2025B of A SecuritiesMaintainedNeutralNeutral
Dec 12, 2025Morgan StanleyMaintainedEqual-WeightEqual-Weight
Nov 24, 2025GuggenheimMaintainedBuyBuy